{"hq_id":"hq-p-pet-000043","name":"Flea and Tick Oral Prevention (Bravecto, NexGard, Simparica)","category":{"primary":"pet_care","secondary":"medication","tags":["oral flea prevention","isoxazoline","NexGard","Bravecto","seizure risk"]},"product_tier":"PET","overall_risk_level":"moderate","description":"Oral flea and tick prevention medications in the isoxazoline class (afoxolaner/NexGard, fluralaner/Bravecto, sarolaner/Simparica). FDA-approved with established efficacy. FDA issued 2018 alert regarding potential for neurological adverse events (seizures, ataxia, tremors) in some dogs, particularly those with seizure history.","synthesis":{"derived_risk_level":"moderate","synthesis_confidence":0.74,"synthesis_method":"compound_composition","context_used":"dog","context_source":"product_users","exposure_modifier":0.722,"vulnerability_escalated":true,"escalation_reason":"Child exposure group","compounds_resolved":1,"compounds_total":1,"synthesis_date":"2026-03-27","synthesis_version":"1.0.0"},"hazard_summary":{"sensitive_populations":"dogs with seizure history, puppies under 8 weeks","overall_risk":"moderate","primary_concerns":["FDA-alerted neurologic adverse events (seizures, tremors, ataxia) in some dogs","Children's accidental ingestion of flavored chewables"],"exposure_routes":"Pet: oral ingestion monthly. Human: incidental handling."},"exposure":{"routes":["oral"],"contact_types":["oral_direct"],"users":["dog","cat","child"],"duration":"minutes","frequency":"monthly","scenarios":["Monthly oral chewable administration to dog","Children handling flavored chewables (accidental ingestion risk)","Dogs with seizure history receiving isoxazoline class"],"notes":"FDA Safety Alert (September 2018): potential for neurologic adverse events with isoxazoline class flea/tick products. Events include muscle tremors, ataxia, and seizures. Most common in dogs with pre-existing seizure disorders. Products remain FDA-approved with label warnings."},"consumer_guidance":{"usage_warning":"Discuss seizure history with veterinarian before prescribing isoxazoline class products. Report any neurologic signs to veterinarian and FDA. Store securely away from children.","safer_alternatives":["Topical flea/tick prevention (non-isoxazoline)","Flea/tick collar (seresto-type, non-oral route)","Environmental flea control as supplement to reduced medication"],"red_flags":[{"indicator":"Product not veterinarian-recommended or approved","meaning":"Unverified safety and efficacy for intended use.","action":"Consult veterinarian before use. Choose NASC or VOHC certified products."}],"green_flags":[{"indicator":"NASC quality seal or veterinary recommendation","meaning":"Third-party quality verification and professional endorsement.","verification":"Look for NASC seal, VOHC acceptance, or FDA CVM approval."}],"what_to_ask":[{"question":"Is this product safe for my specific pet species and breed?","why_it_matters":"Species-specific toxicity varies dramatically (e.g., permethrin lethal to cats, xylitol lethal to dogs).","good_answer":"Yes, tested and labeled for your specific species/breed.","bad_answer":"Generic or unspecified species safety."}],"alternatives":[{"name":"Topical flea/tick prevention","notes":"non-isoxazoline"},{"name":"Flea/tick collar","notes":"seresto-type, non-oral route"},{"name":"Environmental flea control as supplement to reduced medication","notes":"Safer option"}]},"regulatory":{"applicable_regulations":[{"jurisdiction":"USA","regulation":"EPA FIFRA (for pesticide products)","citation":null,"requirements":"Pesticide registration required for flea/tick products. Label directions legally binding.","compliance_status":null,"effective_date":null,"enforcing_agency":"EPA","penalties":null,"source_ref":null},{"jurisdiction":"USA","regulation":"FDA CVM (Center for Veterinary Medicine)","citation":"21 CFR 500-599","requirements":"Animal drugs, feeds, and supplements subject to FDA CVM oversight.","compliance_status":null,"effective_date":null,"enforcing_agency":"FDA CVM","penalties":null,"source_ref":null}],"certifications":[],"labeling":{"required_disclosures":[],"prop65_warning":{"required":null,"chemicals":[],"endpoint":null,"notes":null},"ghs_labeling":{"required":null,"signal_word":null,"pictograms":[],"hazard_statements":[],"notes":null},"hidden_ingredients":{"trade_secret_protected":null,"categories_hidden":[],"estimated_count":null,"known_concerns":null,"notes":null},"notes":null},"recalls":[],"regulatory_gap":null,"notes":null},"lifecycle":{"recyclable":true,"disposal_guidance":"Return unused medication to veterinarian.","hazardous_waste":false,"expected_lifespan":"months"},"formulation":{"form":"varies","key_ingredients":[{"hq_id":"hq-c-org-000183","name":"Fipronil","role":"active_class_reference","concentration_pct":"varies"}],"certifications":[]},"materials":{"common":[{"material_id":null,"material_name":"Primary formulation for flea and tick oral prevention (bravecto, nexgard, simparica)","component":"main product","prevalence":"common","notes":"Standard materials for pet care products."}],"concerning":[],"preferred":[]},"compound_composition":[{"hq_id":"hq-c-org-000183","compound_name":null,"role":"active_class_reference","typical_concentration":"varies"}],"identifiers":{"common_names":["flea and tick oral prevention (bravecto, nexgard, simparica)"],"aliases":[],"manufacturer":null,"brands":[]},"brand_examples":[{"brand":"Heartgard","manufacturer":"Boehringer Ingelheim","market_position":"premium","notable":"Leading heartworm preventative"},{"brand":"NexGard","manufacturer":"Boehringer Ingelheim","market_position":"premium","notable":"Oral flea/tick prevention"},{"brand":"Frontline","manufacturer":"Boehringer Ingelheim","market_position":"mass_market","notable":"Topical flea/tick treatment"}],"sources":[{"type":"expert_curation","name":"ALETHEIA Safety Database","date":"2026-03-25"},{"type":"regulation","title":"EPA FIFRA (for pesticide products)","jurisdiction":"USA","id":"src_fa9eaec6"},{"type":"regulation","title":"FDA CVM (Center for Veterinary Medicine) (21 CFR 500-599)","jurisdiction":"USA","citation":"21 CFR 500-599","id":"src_1f46a430"},{"id":"epa_fipronil_registration_review","type":"regulatory","title":"US EPA: Fipronil Registration Review — Carcinogenicity Classification (Group C), Aquatic Invertebrate and Bee Toxicity, Use Restrictions Near Water, and Risk Mitigation Measures (2017)","year":2017,"inherited_from_compound":"hq-c-org-000183"},{"id":"aspca_fipronil_cats_dogs","type":"veterinary","title":"ASPCA Animal Poison Control Center: Fipronil and Flea/Tick Product Toxicosis in Cats and Dogs — Fipronil vs. Pyrethroid Combination Products, Feline Sulfone Metabolism, Clinical Presentation, and Product Confusion Risk (2023)","year":2023,"inherited_from_compound":"hq-c-org-000183"},{"type":"regulatory","title":"US Food and Drug Administration (FDA)","jurisdiction":"USA","id":"src_82d1cfcd","extraction":"description_reference"}],"meta":{"schema_version":"4.0.0","last_updated":"2026-03-25","timestamp":"2026-05-02T18:31:09.687Z"}}